These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32027015)

  • 1. The role of testosterone in menopausal hormone treatment. What is the evidence?
    Johansen N; Lindén Hirschberg A; Moen MH
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):966-969. PubMed ID: 32027015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Davis SR; Braunstein GD
    J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone use in postmenopausal women.
    Martínez-García A; Davis SR
    Climacteric; 2021 Feb; 24(1):46-50. PubMed ID: 32705895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
    Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
    Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of Testosterone for Postmenopausal Women.
    Pinkerton JV; Blackman I; Conner EA; Kaunitz AM
    Endocrinol Metab Clin North Am; 2021 Mar; 50(1):139-150. PubMed ID: 33518182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Testosterone therapy in female hypoactive sexual desire disorder].
    Meyer P
    Rev Med Suisse; 2016 Mar; 12(510):540-3. PubMed ID: 27149714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Role of Testosterone in The Improvement of Sexual Desire in Postmenopausal Women: An Evidence-Based Clinical Review].
    Gouveia M; Sanches R; Andrade S; Carmona S; Ferreira C
    Acta Med Port; 2018 Nov; 31(11):680-690. PubMed ID: 30521462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR; Graziottin A; Bitzer J; Schmitt S; Koochaki PE; Rodenberg C
    J Sex Med; 2009 Jan; 6(1):175-83. PubMed ID: 19170847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoactive sexual desire disorder in postmenopausal women.
    Nappi RE; Wawra K; Schmitt S
    Gynecol Endocrinol; 2006 Jun; 22(6):318-23. PubMed ID: 16785156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause.
    Ribera Torres L; Anglès-Acedo S; López Chardi L; Mension Coll E; Castelo-Branco C
    Gynecol Endocrinol; 2024 Dec; 40(1):2364220. PubMed ID: 38913119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.